Glucovista is a startup in the healthcare and medical devices industries that was founded in 2006. The company's slogan, "Harnessing infrared technology for a painless and precise glucose monitoring experience, eliminating the need for traditional finger pricking," encapsulates its mission to revolutionize glucose monitoring. Glucovista's innovative approach involves utilizing infrared technology to non-invasively and accurately measure glucose levels in the blood, effectively replacing the traditional finger pricking method.
The company secured a significant $2.73M in its last venture round investment on 23 December 2015. Although the specific investors are not disclosed, this investment signifies the confidence and interest in Glucovista's technology and potential impact on the healthcare and medical devices market. As Glucovista continues to advance its infrared technology for glucose monitoring, it presents a compelling opportunity for investors looking to support groundbreaking solutions in the healthcare industry.
